Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers
Status:
Completed
Trial end date:
2019-05-08
Target enrollment:
Participant gender:
Summary
This study is a randomized, open-label, fasted, single dose, crossover study to evaluate the
pharmacokinetic profiles and safety of CKD-374 5 mg in healthy volunteers.